Abstract
The two year rodent bioassay has been the standard for carcinogenicity screening for 5 decades. However, numerous examples exist showing that a positive result is not predictive of human cancer risk because of lack of relevant dose and/or mode of action. Utilizing basic principles of carcinogenesis, evaluating chemicals for DNA reactivity, immunosuppression, estrogenic activity and increased cell proliferation provides a more scientific, rationally based process for evaluating risk, in conjunction with metabolism in human cell systems and dose response considerations. George Box once stated, “Models; all are wrong, some are useful.” The two year rodent bioassay screen for carcinogenesis is no longer useful.
Original language | English (US) |
---|---|
Pages (from-to) | 6-11 |
Number of pages | 6 |
Journal | Current Opinion in Toxicology |
Volume | 3 |
DOIs | |
State | Published - Apr 1 2017 |
Keywords
- Cell proliferation
- Cytotoxicity
- DNA reactivity
- Estrogen
- Immunosuppression
- Mitogenicity
ASJC Scopus subject areas
- Toxicology